Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Removal of Rifaximin from Pharmaceutical Wastewater: NiFe2O4/GO Nanocomposite as an Efficient Adsorbent

View through CrossRef
Abstract Rifaximin is a widely utilized antibiotic in health care centers and hospitals. However, its elimination from wastewater, which prevents health damages, has not been reported so far. In this work, for the first time, a nanocomposite, NiFe2O4/GO, was employed as an adsorbent to remove Rifaximin from an aqueous solution. After synthesis, the XRD, FT-IR, SEM, and VSM techniques were used to confirm the structure of NiFe2O4/GO. We applied response surface methodology to explore the effects of the NiFe2O4/GO and Rifaximin concentrations, as well as solution pH and contact time, on the process performance. We obtained a high coefficient of determination (R2 = 0.994) and satisfactory predictions from the regression model. We obtained the most favorable adsorption rate (93.39%) at a pH of 4.07, a contact time of 5.5 minutes, an adsorbent concentration of 3147.57 mg/L, and a Rifaximin concentration of 68.50 mg/L. The isotherm studies revealed that the adsorption obeys the Freundlich isotherm with a maximum adsorption capacity of 30.12 mg/g for NiFe2O4/GO at 30°C. Thanks to the calculated thermodynamic parameters, it is declared that the process is spontaneous, and the formation of hydrogen bonds and Van der Waals interactions are the dominant interaction terms between the NiFe2O4/GO and Rifaximin. Moreover, the composite maintained an 85.45% removal rate after 4 cycles of regeneration. A removal rate of 89.45% was obtained for effluent from a local pharmaceutical company, representing good efficiency of the adsorbent. In conclusion, NiFe2O4/GO is shown to be a suitable adsorbent for the elimination of Rifaximin from wastewater.
Research Square Platform LLC
Title: Removal of Rifaximin from Pharmaceutical Wastewater: NiFe2O4/GO Nanocomposite as an Efficient Adsorbent
Description:
Abstract Rifaximin is a widely utilized antibiotic in health care centers and hospitals.
However, its elimination from wastewater, which prevents health damages, has not been reported so far.
In this work, for the first time, a nanocomposite, NiFe2O4/GO, was employed as an adsorbent to remove Rifaximin from an aqueous solution.
After synthesis, the XRD, FT-IR, SEM, and VSM techniques were used to confirm the structure of NiFe2O4/GO.
We applied response surface methodology to explore the effects of the NiFe2O4/GO and Rifaximin concentrations, as well as solution pH and contact time, on the process performance.
We obtained a high coefficient of determination (R2 = 0.
994) and satisfactory predictions from the regression model.
We obtained the most favorable adsorption rate (93.
39%) at a pH of 4.
07, a contact time of 5.
5 minutes, an adsorbent concentration of 3147.
57 mg/L, and a Rifaximin concentration of 68.
50 mg/L.
The isotherm studies revealed that the adsorption obeys the Freundlich isotherm with a maximum adsorption capacity of 30.
12 mg/g for NiFe2O4/GO at 30°C.
Thanks to the calculated thermodynamic parameters, it is declared that the process is spontaneous, and the formation of hydrogen bonds and Van der Waals interactions are the dominant interaction terms between the NiFe2O4/GO and Rifaximin.
Moreover, the composite maintained an 85.
45% removal rate after 4 cycles of regeneration.
A removal rate of 89.
45% was obtained for effluent from a local pharmaceutical company, representing good efficiency of the adsorbent.
In conclusion, NiFe2O4/GO is shown to be a suitable adsorbent for the elimination of Rifaximin from wastewater.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Evaluating carbon dots as electron mediators in photochemical and photocatalytic processes of NiFe2O4
Evaluating carbon dots as electron mediators in photochemical and photocatalytic processes of NiFe2O4
Spinel ferrites such as nickel ferrite are promising energy conversion photocatalysts as they are visible-light absorbers, chemically stable, earth abundant, and inexpensive. Nicke...
Rifaximin Treatment of Collagenous Colitis: A Randomised, Double-Blind, Placebo-Controlled Trial
Rifaximin Treatment of Collagenous Colitis: A Randomised, Double-Blind, Placebo-Controlled Trial
<b><i>Introduction:</i></b> Collagenous colitis (CC) is a disabling disease primarily affecting elderly women. Sparse, well-documented treatment modalities ...
Eradication of <i>Helicobacter pylori</i>: Are Rifaximin-Based Regimens Effective?
Eradication of <i>Helicobacter pylori</i>: Are Rifaximin-Based Regimens Effective?
Rifaximin is a non-absorbed semisynthetic rifamycin derivative with a broad spectrum of antibacterial activity including Gram-positive and Gram-negative bacteria, both aerobes and ...
Optimization of congo red removal by adsorption onto NiFe2O4/GO nanocomposite
Optimization of congo red removal by adsorption onto NiFe2O4/GO nanocomposite
The present study focused on the use of the magnetic nanocomposite NiFe2O4/GO (GO - Graphene oxide) as an efficient adsorbent for the removal of congo red (CR). The NiFe2O4/GO was ...
Frequency of Recurrence of Hepatic Encephalopathy in Patients of Chronic Liver Disease Treated With Rifaximin
Frequency of Recurrence of Hepatic Encephalopathy in Patients of Chronic Liver Disease Treated With Rifaximin
Aim: To determine the frequency of recurrence of hepatic encephalopathy in patients treated with Rifaximin. Study design: Observational cross-sectional study. Setting & duratio...
Efficacy of Rifaximin in Relieving Symptoms of IBS-D: Experience from a Public Hospital in Pakistan
Efficacy of Rifaximin in Relieving Symptoms of IBS-D: Experience from a Public Hospital in Pakistan
Background: Irritable Bowel Syndrome with Diarrhea (IBS-D) is a prevalent and distressing gastrointestinal disorder, particularly in South Asia, where evidence for rifaximin’s effi...

Back to Top